Then we analyzed the levels of both Nrf2 and CXCL10 measured in follicular fluids of the study participants divided in three groups: healthy controls, BC patients without lymph node metastasis and with lymph node metastasis. This evidence concerns the gene CXCL10 and breast cancer.